|
Volumn 7, Issue 18 SUPP., 2001, Pages
|
The managed care pharmacy perspective
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CONJUGATED ESTROGEN;
ORAL CONTRACEPTIVE AGENT;
ABORTION;
CANCER;
CARDIOVASCULAR DISEASE;
CONFERENCE PAPER;
CONTRACEPTION;
COST BENEFIT ANALYSIS;
COST CONTROL;
DEPRESSION;
DRUG COST;
ECONOMIC EVALUATION;
ECTOPIC PREGNANCY;
FERTILITY;
FOLLOW UP;
HEALTH CARE COST;
HEALTH CARE NEED;
HORMONAL THERAPY;
HORMONE SUBSTITUTION;
HUMAN;
MANAGED CARE;
MANAGED CARE ORGANIZATION;
MEDICAL RESEARCH;
MENOPAUSE;
OSTEOPOROSIS;
OUTCOMES RESEARCH;
PATIENT COMPLIANCE;
PHARMACY;
PREGNANCY;
PRESCRIPTION;
PRIORITY JOURNAL;
SIDE EFFECT;
CLIMACTERIC;
CONTRACEPTIVES, ORAL, HORMONAL;
ECONOMICS, PHARMACEUTICAL;
FEMALE;
HORMONE REPLACEMENT THERAPY;
HUMANS;
MANAGED CARE PROGRAMS;
OUTCOME ASSESSMENT (HEALTH CARE);
PHARMACEUTICAL SERVICES;
UNITED STATES;
|
EID: 0035199104
PISSN: 10880224
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (1)
|
References (15)
|